These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat. Smith SA; Lister CA; Toseland CD; Buckingham RE Diabetes Obes Metab; 2000 Dec; 2(6):363-72. PubMed ID: 11225966 [TBL] [Abstract][Full Text] [Related]
14. AZ 242, a novel PPARalpha/gamma agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats. Ljung B; Bamberg K; Dahllöf B; Kjellstedt A; Oakes ND; Ostling J; Svensson L; Camejo G J Lipid Res; 2002 Nov; 43(11):1855-63. PubMed ID: 12401884 [TBL] [Abstract][Full Text] [Related]
15. Insulin resistance and its treatment by thiazolidinediones. Lebovitz HE; Banerji MA Recent Prog Horm Res; 2001; 56():265-94. PubMed ID: 11237217 [TBL] [Abstract][Full Text] [Related]
16. A novel peroxisome proliferator-activated gamma (PPAR gamma) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential. Dey D; Medicherla S; Neogi P; Gowri M; Cheng J; Gross C; Sharma SD; Reaven GM; Nag B Metabolism; 2003 Aug; 52(8):1012-8. PubMed ID: 12898466 [TBL] [Abstract][Full Text] [Related]
18. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats. Murakami K; Tobe K; Ide T; Mochizuki T; Ohashi M; Akanuma Y; Yazaki Y; Kadowaki T Diabetes; 1998 Dec; 47(12):1841-7. PubMed ID: 9836514 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative. Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726 [TBL] [Abstract][Full Text] [Related]
20. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone. Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]